Amgen SVP reports tax-withholding on 88 shares

Amgen Inc. senior vice president and chief compliance officer Nancy A. Grygiel reported routine share activity involving Amgen common stock.

Rhea-AI Filing Summary

Amgen Inc. senior vice president and chief compliance officer Nancy A. Grygiel reported routine share activity involving Amgen common stock. The filing shows a tax-withholding disposition of 88 shares of common stock at $331.11 per share, used to cover tax obligations rather than representing an open-market sale. After this transaction, she holds 7,330 Amgen shares directly. The filing also notes an indirect holding of 106.1864 shares in a 401(k) plan, which includes 58 Dividend Equivalents tied to unvested Restricted Stock Units that will be paid out in shares as they vest.

Insights

Equity compensation and governance analyst

Form 4 shows routine tax withholding and small 401(k) holdings.

The filing for Nancy A. Grygiel at Amgen Inc. records an F-code tax-withholding disposition of 88 shares at $331.11 per share. F-code events typically reflect automated share withholding to satisfy tax liabilities on equity compensation rather than discretionary selling.

Following the transaction, Grygiel holds 7,330 shares directly, plus 106.1864 shares indirectly in a 401(k) plan that includes 58 Dividend Equivalents linked to unvested Restricted Stock Units. With no open‑market buys or sells and no remaining derivatives listed, this filing reads as routine compensation and retirement-plan administration.

Insider Trade Summary

Exercise Price or Tax Liability: 88 shares

Exercise Price or Tax Liability 2 txns

Insider Grygiel Nancy A.

Role SVP & CCO

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	88	$331.11	$29K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 7,330 shares (Direct); Common Stock — 106.1864 shares (Indirect, 401(k) Plan)

Footnotes (1)

1. F1. These shares include 58 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Key Figures

Tax-withheld shares: 88 shares Withholding price: $331.11 per share Direct holdings after transaction: 7,330 shares +2 more

5 metrics

Tax-withheld shares 88 shares F-code tax-withholding disposition at $331.11 per share

Withholding price $331.11 per share Price used for 88-share tax-withholding disposition

Direct holdings after transaction 7,330 shares Amgen common stock held directly by Nancy A. Grygiel

401(k) Plan holdings 106.1864 shares Indirect Amgen holdings in 401(k) Plan, including Dividend Equivalents

Dividend Equivalents 58 DEs Credited under 2009 Equity Incentive Plan to unvested RSUs

Key Terms

tax-withholding disposition, Dividend Equivalents, Restricted Stock Units, 401(k) Plan, +1 more

5 terms

tax-withholding disposition financial

"transaction_action: "tax-withholding disposition" for the 88-share event"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Dividend Equivalents financial

"These shares include 58 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"

Payments tied to employee or contractor equity awards that mirror the cash dividends paid on the company’s stock; they give the holder the same economic benefit as owning the shares without transferring actual shares—often paid in cash or additional award units when the award becomes payable. Investors care because these payments affect a company’s compensation costs, cash flow and potential share dilution, and they signal how management is being rewarded and aligned with shareholders.

Restricted Stock Units financial

"DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

401(k) Plan financial

"total_shares_following_transaction: "106.1864"; nature_of_ownership: "401(k) Plan""

A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.

Equity Incentive Plan financial

"granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Amgen (AMGN) executive Nancy Grygiel report in this Form 4?

Nancy A. Grygiel reported a tax-withholding disposition of 88 Amgen common shares at $331.11 per share. This F-code transaction covers tax obligations on equity compensation rather than an open-market sale, and leaves her with 7,330 directly held shares afterward.

Was the Amgen (AMGN) Form 4 transaction an open-market sale?

The Form 4 shows an F-code tax-withholding disposition, not an open-market sale. 88 shares were delivered at $331.11 per share to satisfy tax liability, a routine mechanism when equity awards vest or are exercised, without indicating discretionary selling activity.

How many Amgen (AMGN) shares does Nancy Grygiel hold after this filing?

After the reported tax-withholding event, Nancy A. Grygiel holds 7,330 Amgen common shares directly. She also has 106.1864 shares indirectly through a 401(k) plan, which includes 58 Dividend Equivalents tied to unvested Restricted Stock Units that will pay out in shares upon vesting.

What is the significance of the 401(k) Plan holding in the Amgen (AMGN) Form 4?

The Form 4 lists an indirect holding of 106.1864 Amgen shares in a 401(k) Plan. This amount includes 58 Dividend Equivalents credited to unvested Restricted Stock Units, which will be paid in Amgen common stock as the underlying units vest, plus cash for fractional amounts.

What are Dividend Equivalents mentioned in the Amgen (AMGN) insider filing?

Dividend Equivalents are credits that mirror dividends on unvested Restricted Stock Units. In this filing, 58 Dividend Equivalents were granted under Amgen’s 2009 Equity Incentive Plan and are paid out in Amgen common shares on a one-to-one basis as the related RSUs vest, with cash for fractional shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/11/2026 - 08:02 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Grygiel Nancy A.

(Last) (First) (Middle)

ONE AMGEN CENTER DRIVE

(Street)

THOUSAND OAKS CALIFORNIA 91320

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMGEN INC [ AMGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP & CCO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/07/2026		F		88	D	$331.11	7,330(1)	D
Common Stock								106.1864	I	401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares include 58 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

	/s/ Nancy A. Grygiel	05/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)